Related Articles
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism
Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies
COMPARISON OF ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS GENERATED BY IL-2 AND IL-7 - CELLULAR MODIFICATIONS INDUCED BY IL-7
INTERLEUKIN-4 INHIBITS LAK AND INITIAL PHASE TIL ACTIVITY VIA INTERLEUKIN-2 RECEPTOR
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro